SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
pharmaceutical industry
Trump Taps 'Manifestly Unqualified' Peter Thiel Protégé as Acting CDC Director After RFK's Purge
A health researcher for Public Citizen said Trump's interim CDC director has "no medical or public health background and extremist libertarian views."
Aug 29, 2025
After pushing out his own handpicked Centers for Disease Control and Prevention (CDC) director, infectious disease expert Susan Monarez, fueling a wave of outraged resignations this week, US President Donald Trump has appointed a loyal acolyte to replace her at Health and Human Services Secretary Robert F. Kennedy Jr.'s side.
On Thursday, the president tapped one of RFK's top aides as interim CDC director: biotech investor Jim O'Neill, a man with no medical experience but extensive experience profiting from healthcare while working at billionaire GOP megadonor Peter Thiel's venture capital firm, Mithril Capital.
Unlike his predecessor, whose ouster came as she tried to push back against RFK's anti-vaccine agenda, O'Neill fits snugly into the secretary's efforts to restrict access to the Covid-19 vaccine, and potentially ban it outright, as the Daily Beast reported earlier this week.
"A tech investor with no medical or public health background and extremist libertarian views, Jim O'Neill was unfit for the number two position at HHS and manifestly unqualified to lead the CDC," said Dr. Robert Steinbrook, director of Public Citizen's health research group, on Friday.
Just as Kennedy did during his confirmation hearings, O'Neill insisted he was "pro-vaccine," noting that he was "an adviser to a vaccine company." However, this is belied by his record on the subject.
He has championed unproven cures like ivermectin, hydroxychloroquine, and vitamin D supplements to protect against Covid-19, and has accused the CDC under the administration of former President Joe Biden of downplaying the vaccine's dangers while railing against mandates.
O'Neill has also praised Kennedy's response to the measles outbreak that swept across the US earlier this year, during which the secretary downplayed the severity and cast unfounded doubt on the effectiveness and safety of the measles vaccine that had virtually eradicated the disease before vaccination rates began to decline.
"Unlike Susan Monarez," Steinbrook said, "O'Neill is likely to rubber-stamp dangerous vaccine recommendations from HHS Secretary Kennedy's handpicked appointees to the Advisory Committee on Immunization Practices and obey orders to fire CDC public health experts with scientific integrity."
O'Neill melds medical crankery with a Thielite strain of anarcho-libertarianism. He has served on the board of the Seasteading Institute, an organization founded by Patri Friedman, the grandson of the right-wing economist Milton Friedman, who advocates for corporations like Apple and Google to form their own floating cities at sea, which would be governed as corporate "dictatorships" free from the constraints of democratic governance.
That anti-government ethos extends to his views on the healthcare system, which O'Neill says is flawed not because of the rampant profiteering of the private companies that run it, but because it is supposedly not "free market" enough.
In 2014, he advocated for the Food and Drug Administration (FDA) to begin approving drugs for the market without conducting clinical trials to determine their effectiveness. "Let people start using them, at their own risk," he argued, "Let's prove efficacy after they've been legalized."
He has also argued for the government to allow people to sell their own internal organs. This process often results in deteriorating health for the disproportionately poor people who partake.
While working at HHS under the administration of former President George W. Bush, O'Neill also opposed the FDA regulation of companies that use algorithms to perform laboratory tests.
At the time, he was focused on DNA testing products like 23andMe, but a report from the consumer watchdog group Public Citizen says that "a decade after he made this remark, it's clear how dangerous such a concept is," noting that "with the development and proliferation of artificial intelligence, algorithms are omnipresent in the practice of medicine, including in diagnostic tools, medical devices, AI assistants to doctors, and personalized medicine."
In addition to Thiel's ideology, he reportedly brings several conflicts of interest to the CDC director job from his time working at Thiel's venture capital firm.
Accountable.US reported Friday that O'Neill "took money from, helped incubate, or was otherwise linked to at least eight medical industry startups with direct business before the department he could help run."
These include firms he advised, like the pharmaceutical company ADvantage Therapeutics or the National Institutes of Health grantee Rational Vaccines, which manufactures herpes drugs.
It also includes four companies seeded by his Thiel-affiliated venture capital firm Breakout Labs, some of which have received government funding or have products awaiting FDA approval.
Though O'Neill agreed to divest from some of these companies and abstain from involvement in decision-making with them as part of his ethics agreement, the report notes that "he did not promise to abstain from decisions involving these companies for the duration of his term, or to abstain from doing business with them after departing HHS."
"O'Neill would be in a prime position to ensure favorable outcomes for several medical industry startups he's been financially linked to that have direct business before HHS and the CDC," said Accountable.US executive director Tony Carrk. "How can American patients be sure that proper vetting of these companies would take place on O'Neill's watch and that public health will be a higher priority over the profits of his former clients?"
Though Steinbrook describes O'Neill as "manifestly unqualified" for the position, he said, "No credible public health authority is likely to work for Kennedy, who is dictating the agency's decisions based on whim, not science."
"The only path forward," Steinbrook said, "is for Kennedy to go, which Congress, professional organizations, medical journals, and the public should demand."
Keep ReadingShow Less
Trump Tariffs Show GOP Aims to Make Working Class Fund 'Payday for Billionaires and Giant Corporations'
One critic said the party's "top priority is making working- and middle-class families pay more for healthcare, lifesaving medications, food, cars, and electronics, all to fund more tax breaks for the ultrawealthy."
Feb 19, 2025
The national campaign Unrig Our Economy said Wednesday that U.S. President Donald Trump's promise of tariffs targeting the automobile industry, pharmaceuticals, and semiconductor chips is just the latest evidence that elected Republicans are prioritizing megarich individuals and corporations, not working people.
"This action is further proof that Republicans' top priority is making working- and middle-class families pay more for healthcare, lifesaving medications, food, cars, and electronics, all to fund more tax breaks for the ultrawealthy," said Unrig Our Economy spokesperson Kobie Christian in a statement.
The statement followed Trump discussing the forthcoming tariffs with reporters on Tuesday at his Florida residence, Mar-a-Lago. Bloomberg's Hadriana Lowenkron asked about his plans for new taxes on imports.
For the auto industry, "I probably will tell you that on April 2, but it'll be in the neighborhood of 25%," Trump said. For pharmaceuticals and semiconductors, he added, "it'll be 25% and higher, and it'll go very substantially higher over course of a year," giving those industries some time to set up U.S. factories to avoid the tariffs.
On April 1, "members of his Cabinet are due to deliver reports to him outlining options for a range of import duties as he seeks to reshape global trade," Reuters reported.
Trump's 10% tariff for imports from China has taken effect, but his 25% tariffs targeting Canada and Mexico have been delayed.
David Greene, an industry analyst at Cars.com, told CNN that "if the administration moves forward with a 25% tariff on all auto imports, car shoppers should get ready for some sticker shock at dealerships."
"If new car prices increase, more buyers will shift toward used vehicles, and as demand rises, so will prices," Greene said.
The president's latest comments on tariffs came after Republicans in the U.S. House of Representatives last week advanced out of committee a budget plan that would cut healthcare and food assistance programs to fund tax giveaways for the rich.
The Economic Policy Institute last week released a report detailing how extending the expiring provisions from the tax law that Republican lawmakers passed and Trump signed in 2017 "will have painful trade-offs for the U.S. economy and most Americans."
Christian said Wednesday that "even as the cost of everyday goods continues to rise and Trump and the billionaires in his administration arbitrarily cut programs that help feed children and seniors, Republicans in Congress are still pushing forward an agenda that would give billions in handouts to the wealthiest few, while leaving the rest of us behind."
"Our representatives in Congress need to look out for their constituents," the spokesperson added, "instead of prioritizing cost-raising tariffs to bankroll a massive payday for billionaires and giant corporations."
Keep ReadingShow Less
'This Absurdity Must End,' Sanders Says of Study Highlighting Healthcare Industry Greed
"Unfortunately, instead of working with Congress on this real issue, Trump and Musk have launched an immoral and unconstitutional attack on the Department of Health and Human Services."
Feb 12, 2025
Responding to a new study showing that leading health services companies made $2.7 trillion in profits and spent $2.6 trillion on stock buybacks and dividends in the years 2001-22, U.S. Sen. Bernie Sanders on Wednesday vowed to continue "to take on the unprecedented level of corporate greed in our healthcare system."
The study, published this week by the Journal of the American Medical Association, noted the "growing concern that a large proportion of U.S. healthcare spending appears to be directed to corporate shareholders rather than enhancing affordable access, improving quality of care, or advancing research and development."
Sanders (I-Vt.)—the ranking member of the Senate Committee on Health, Education, Labor, and Pensions—said in a statement that "it is absolutely unacceptable that since 2001, the top healthcare companies in America spent 95% of their profits, $2.6 trillion, not to make Americans healthy, but to make their CEOs and stockholders obscenely rich."
The top health care companies in America spent 95% of their profits to make their CEOs & stockholders obscenely rich. How many Americans would be alive today if those companies spent $2.6 trillion on disease prevention and primary care, instead of stock buybacks and dividends?
[image or embed]
— Senator Bernie Sanders (@sanders.senate.gov) February 12, 2025 at 11:21 AM
"The function of a rational healthcare system is to guarantee quality healthcare to all, not huge payouts for stockholders and executives in the drug and insurance industries," Sanders asserted. "None of this money was used to search for new treatments and cures, to lower prices, or to improve patient care. That has got to change."
The senator continued:
This study confirms that the greatest waste, fraud, and abuse in this country is corporate greed. Unfortunately, instead of working with Congress on this real issue, [U.S. President Donald] Trump and [Department of Government Efficiency leader Elon] Musk have launched an immoral and unconstitutional attack on the Department of Health and Human Services.
Instead of taking on the greed of the pharmaceutical industry, Trump and Musk are taking away AIDS treatment from poor people.
Instead of taking on the for-profit insurance industry, Trump and Musk are making it harder for working-class Americans to get the healthcare they need through Medicaid and community health centers.
"This absurdity must end," Sanders stressed. "As the ranking member of the Senate Health, Education, Labor, and Pensions Committee, I will do everything I can to take on the unprecedented level of corporate greed in our healthcare system."
Last month, Sanders—who twice sought the Democratic presidential nomination on a platform centering Medicare for All—unveiled a nine-point "Make America Healthy Again" plan in response to Health and Human Services secretary nominee Robert F. Kennedy Jr.'s variation on Trump's "Make America Great Again" slogan.
Keep ReadingShow Less
Most Popular